Back to results
US 5,843,899 AGranted
Use of insulin-like growth factors I and II for inhibition of inflammatory response
AssigneeCiba-Geigy Corporation
InventorPhilip F. Halloran
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for using IGF as inhibitors of inflammatory response, ischemic injury, and organ rejection.
Claims8
A method for inhibition of an inflammatory response in a mammal that has an inflammatory condition, wherein said inflammatory condition causes degeneration of cartilage, pancreatic cells, brain cells or gastrointestinal cells, said method comprising administering thereto an inflammatory response inhibitory dose of IGF sufficient to inhibit degeneration of said cartilage, pancreatic cells, brain cells or gastrointestinal cells.
Dependencies are inferred from the claim text.